PMC · DOI:10.1016/j.gendis.2024.101257·March 5, 2024
Disulfidptosis heterogeneity in breast cancer uncovers PTTG1IP as an actionable therapeutic target
Kun Fang, Suxiao Jiang, Zhengjie Xu, Meng Luo, Changsheng Yan
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Figures15
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFerroptosis and cancer prognosis · MicroRNA in disease regulation · Epigenetics and DNA Methylation